Assessment of the validity of the 28-joint disease activity score using erythrocyte sedimentation rate (DAS28-ESR) as a disease activity index of rheumatoid arthritis in the efficacy evaluation of 24-week treatment with tocilizumab: subanalysis of the SATORI study

As tocilizumab (TCZ) greatly inhibits inflammatory markers, methods of evaluating rheumatoid arthritis (RA) disease activity that include inflammatory markers may overestimate the effect of TCZ treatment. We have evaluated the impact of inflammatory markers on the efficacy of TCZ by comparing the ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishimoto, Norihiro, Takagi, Nobuhiro
Formato: Texto
Lenguaje:English
Publicado: Springer Japan 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2999727/
https://www.ncbi.nlm.nih.gov/pubmed/20617358
http://dx.doi.org/10.1007/s10165-010-0328-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2999727/
https://www.ncbi.nlm.nih.gov/pubmed/20617358
http://dx.doi.org/10.1007/s10165-010-0328-0

Ejemplares similares